Personalised medicine appears to be an inevitable future of health care, and economists aren’t ready for it. It has various monikers and related concepts including precision medicine, stratified medicine, pharmacogenomics, pharmacogenetics and predictive medicine. But, whatever you… Read More »Economics of personalised medicine: an introduction
Economics is largely about trade-offs and compromise. Academics study the former but don’t often engage in the latter. In health economics, as in other fields, a key trade-off is between equity and efficiency. We’ve been studying… Read More »The potential of the super QALY to reconcile the key contentions in health economics
An argument that often comes up when it comes to the distribution of scarce health resources is who should receive them. Many different arguments are posed with varying degrees of sophistication. Various studies have elicited… Read More »To whom the benefits?
A recent article by Benjamin Ho and Sita Nataraj Slavov, which I picked up via Marginal Revolution, argues that health inequality is falling. The argument is that life expectancy for the 1% dying at the bottom end… Read More »A comment on health inequality